首页> 外文期刊>Acta medica Iranica. >Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients.
【24h】

Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients.

机译:在非酒精性脂肪肝患者中具有心血管疾病,糖尿病,血脂异常和高血压的阳性家族史的预测价值。

获取原文
           

摘要

In the present study, we examined the relationship between family history of cardiovascular diseases (CVD), dyslipidemia, hypertension, and diabetes with laboratorial abnormalities and syndromes in Iranian patients with non-alcoholic fatty liver disease (NAFLD). A total of 332 NAFLD patients from our outpatient clinic were consecutively entered into analysis. Exclusion criteria were having diabetes mellitus and fasting blood glucose over 126, active hepatitis B virus infection, having HCV positive serology, and to be under corticosteroid therapy. Family history of CVD, diabetes, dyslipidemia, and hypertension were taken from patients and related to the study variables. Family history of cardiovascular diseases (CVD) was associated with low HDL levels (P=0.05). Patients with positive family history of diabetes mellitus were significantly more likely to have AST/ALT levels proportion of higher than one (P=0.044). Family history of dyslipidemia was a predictor for hypertriglyceridemia (P=0.02), higher prothrombin time levels (P=0.013), lower albumin (P=0.024) and T4 (P=0.043) levels. Family history of hypertension was associated with dysglycemia/diabetes (P=0.038), high ALT (P=0.008), and low TIBC (P=0.007) and albumin levels (P=0.001). Family history for CVD, diabetes, dyslipidemia, and hypertension were of clinical importance in the Iranian patients with NAFLD. We therefore recommend that physicians should precisely get family history of main disorders in all NAFLD patients; and to pay more attention to those having the mentioned family histories. Further studies with larger patient population and prospective approach are needed for confirming our findings.
机译:在本研究中,我们检查了伊朗非酒精性脂肪肝病(NAFLD)患者的心血管疾病(CVD),血脂异常,高血压和糖尿病家族史与实验室异常和综合征之间的关系。我们的门诊诊所共有332名NAFLD患者被连续纳入分析。排除标准为糖尿病和空腹血糖超过126,活动性乙型肝炎病毒感染,HCV阳性血清学以及接受糖皮质激素治疗。 CVD患者的家族史,糖尿病,血脂异常和高血压均来自患者,并与研究变量相关。心血管疾病家族史(CVD)与低水平的HDL有关(P = 0.05)。糖尿病家族史阳性的患者更有可能AST / ALT水平比例高于1(P = 0.044)。血脂异常家族史是高甘油三酯血症(P = 0.02),凝血酶原时间水平较高(P = 0.013),白蛋白水平较低(P = 0.024)和T4水平(P = 0.043)的预测指标。高血压的家族史与血糖/糖尿病(P = 0.038),ALT高(P = 0.008),TIBC低(P = 0.007)和白蛋白水平(P = 0.001)有关。 CVD,糖尿病,血脂异常和高血压的家族史在伊朗NAFLD患者中具有重要的临床意义。因此,我们建议医师应准确掌握所有NAFLD患者的主要疾病家族史;并更多地关注那些具有上述家族史的人。需要进一步的研究以更大的患者群体和前瞻性方法来证实我们的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号